Barad; David H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Barad; David H..The latest application filed is for "dehydroepiandrosterone (dhea) supplementation on female sexual desire and function in pre-menopausal women".

Company Profile

3.27.28

Barad; David H. - Closter NJ
Barad; David H. - New York NY US
Barad; David H. - US
Barad; David H - Closter NJ US
Barad; David H. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diagnosis and anti-Mullerian hormone (AMH) administration for treatment of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models Grant 10,884,003 - Gleicher , et al. January 5, 2	2021-01-05
Dehydroepiandrosterone (dhea) Supplementation On Female Sexual Desire And Function In Pre-menopausal Women App 20200030342 - Gleicher; Norbert ; et al.	2020-01-30
Diagnosis, And Anti-mullerian Hormone (amh) Administration For Treatment, Of Infertility For Good-, Intermediate- And Poor-progn App 20190195895 - Gleicher; Norbert ; et al.	2019-06-27
Diagnosis, and anti-mullerian hormone (AMH) administration for treatment, of infertility for good-, intermediate- and poor-prognosis patients for in vitro fertilization in view of logistic regression models Grant 10,175,252 - Gleicher , et al. J	2019-01-08
Administration to improve oocyte retrieval probabilities Grant 9,974,834 - Gleicher , et al. May 22, 2	2018-05-22
Oocyte Retrieval Probabilities Based On Anti- Mullerian Hormone (amh) Levels In Poor Pregnancy Prognosis Patients With Small Oocyte Yields -- Selection And Amh Administration Thereof App 20170252404 - Gleicher; Norbert ; et al.	2017-09-07
Diagnosis, And Anti-mullerian Hormone (amh) Administration For Treatment, Of Infertility For Good-, Intermediate- And Poor-prognosis Patients For In Vitro Fertilization In View Of Logistic Regression Models App 20170227554 - Gleicher; Norbert ; et al.	2017-08-10
Androgen treatment in females Grant 9,375,436 - Gleicher , et al. June 28, 2	2016-06-28
Androgen treatment in females Grant 9,205,092 - Gleicher , et al. December 8, 2	2015-12-08
Screening of oocyte donor candidates based on the FMR1 gene Grant 9,157,117 - Gleicher , et al. October 13, 2	2015-10-13
Methods of treatment relating to the FMR1 gene Grant 9,114,153 - Gleicher , et al. August 25, 2	2015-08-25
Androgen treatment in females Grant 9,056,115 - Gleicher , et al. June 16, 2	2015-06-16
Detection of infertility risk and premature ovarian aging Grant 8,951,724 - Gleicher , et al. February 10, 2	2015-02-10
Screening Of Oocyte Donor Candidates Based On The Fmr1 Gene App 20140243585 - Gleicher; Norbert ; et al.	2014-08-28
Detection Of Infertility Risk And Premature Ovarian Aging App 20140206756 - Gleicher; Norbert ; et al.	2014-07-24
Methods Of Treatment Relating To The Fmr1 Gene App 20140100264 - Gleicher; Norbert ; et al.	2014-04-10
Androgen Treatment In Females App 20140038930 - Gleicher; Norbert ; et al.	2014-02-06
Method of treatments related to the FMR1 gene Grant 8,629,120 - Gleicher , et al. January 14, 2	2014-01-14
Androgen Treatment In Females App 20140011787 - Gleicher; Norbert ; et al.	2014-01-09
Androgen treatment in females Grant 8,501,719 - Gleicher , et al. August 6, 2	2013-08-06
Androgen treatment in females Grant 8,501,718 - Gleicher , et al. August 6, 2	2013-08-06
Method Of Treatments Related To The Fmr1 Gene App 20130012569 - GLEICHER; Norbert ; et al.	2013-01-10
Analyzing The Fmr1 Gene App 20120129957 - GLEICHER; Norbert ; et al.	2012-05-24
Androgen treatment in females Grant 8,067,400 - Gleicher , et al. November 29, 2	2011-11-29
Androgen Treatment in Females App 20110207708 - Gleicher; Norbert ; et al.	2011-08-25
Analyzing the FMR1 Gene App 20110159494 - GLEICHER; Norbert ; et al.	2011-06-30
Analyzing The Fmr1 Gene App 20110020795 - GLEICHER; Norbert ; et al.	2011-01-27
Androgen Treatment In Females App 20100113407 - Gleicher; Norbert ; et al.	2010-05-06
Androgen Treatment In Females App 20100048525 - GLEICHER; Norbert ; et al.	2010-02-25
Method of improving cumulative embryo score and quantity of fertilized oocytes, increasing euploidy rate and of normalizing ovarian function using an androgen such as dehydroepiandrosterone Grant 7,615,544 - Gleicher , et al. November 10, 2	2009-11-10
Androgen Treatment in Females App 20080269180 - GLEICHER; Norbert ; et al.	2008-10-30
Androgen Treatment in Females App 20070155710 - GLEICHER; Norbert ; et al.	2007-07-05
Method of improving cumulative embryo score and quantity of fertilized ooytes, increasing euploidy rate and of normalizing ovarian function using an androgen such as dehydroepiandrosterone App 20060089339 - Gleicher; Norbert ; et al.	2006-04-27
Method of improving ovulation induction using an androgen such as dehydroepiandrosterone App 20060089308 - Gleicher; Norbert ; et al.	2006-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.